Effects of Sodium/Glucose Cotransporter 2 (SGLT2) Inhibitors on Cardiovascular and Metabolic Outcomes in Patients Without Diabetes Mellitus: A Systematic Review and Meta‐Analysis of Randomized‐Controlled Trials

Background Recent studies have increasingly shown that sodium‐glucose cotransporter 2 (SGLT2) inhibitors may have beneficial cardiovascular and metabolic effects in patients without diabetes mellitus. Hence, we conducted a systematic review and meta‐analysis to determine the effect of SGLT2 inhibito...

Descripció completa

Dades bibliogràfiques

Autors principals:	Yao Hao Teo, Yao Neng Teo, Nicholas L. Syn, Cheryl Shumin Kow, Celine Shuen Yin Yoong, Benjamin Y. Q. Tan, Tiong‐Cheng Yeo, Chi‐Hang Lee, Weiqin Lin, Ching‐Hui Sia
Format:	Artigo
Idioma:	Inglês
Publicat:	Wiley 2021-03-01
Col·lecció:	Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease
Matèries:	nondiabetics sodium/glucose cotransporter 2 inhibitors
Accés en línia:	https://www.ahajournals.org/doi/10.1161/JAHA.120.019463
Etiquetes:	Afegir etiqueta Sense etiquetes, Sigues el primer a etiquetar aquest registre!